Antibodies in drug discovery
9 - 10 Feb 2016
Cripps Court, Cambridge, United Kingdom of Great Britain and Northern Ireland
Over the last several years, rapid progress has been made in the area of antibodies for drug discovery.
The goals of this workshop are to fully explore the latest developments in the designing and engineering of antibodies as it relates to the burgeoning field of biotherapeutics.
Topics to be addressed, will be engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in discovery for autoimmune and infectious diseases.
You will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of antibody discovery, whilst networking with the technology providers who are enabling them to do so.
Agenda Topics
-
Antibody Drug Conjugates (ADCs)
-
CAR/CAR-T Cells
-
Humanised Single Domain Antibodies for Research and Therapeutic Applications
-
Novel Immune Check Point Therapeutics, PD1 and Beyond
-
Patented Antibodies and Related Technologies in Europe
-
Targeting Ion Channels with Biologics
No items were found.
